WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark PEREGRINE was filed as Word mark on 10/26/2020 at the World Intellectual Property Organization.
| Trademark form | Word mark |
| File reference | 1572716 |
| Countries | 
|
| Base trademark |
No. 1421682,
July 22, 2020
|
| Application date | October 26, 2020 |
| Expiration date | October 26, 2030 |
Trademark owner
Lichtenauerlaan 40
3062 ME Rotterdam
NL
3062 ME Rotterdam
NL
Trademark representatives
Carnegieplein 5
2517 KJ Den Haag
NL
goods and services
05
Molecular diagnostic test reagents; molecular diagnostic
test reagents of body substances, such as bone marrow
samples, blood samples, and on human or animal tissue;
molecular diagnostic test reagents for cancer; molecular
diagnostic test reagents, inter alia on the basis of
microarray technology (next generation) sequencing
technology; reagents for use in medical genetic testing;
reagents for use in medical genetic testing for the
measurement of the gene expression profile; reagents for use
in medical genetic testing for the measurement of gene
aberrations and mutations; clinical diagnostic test reagents
for determination of genetic sub-type of a patient;
prognostic test reagents; predictive test reagents, in
search of the effectiveness of a medical treatment and/or to
select the medical treatment; diagnostic test reagents and
preparations for medical or veterinary purposes; chemical
preparations, for medical purposes, for the testing of blood
and human or animal tissue, including cancer cells; medical
diagnostic test strips; diagnostic testing materials for
medical use; preparations for detecting mutation in genes
for medical purposes
42
Research and development of new products for others;
biochemical research and development; pharmaceutical
research and development; research and development in the
field of diagnostic preparations; biological research,
clinical research and medical research; scientific research
for the benefit of the development of molecular diagnostic
tests; analysis and evaluation of results from quality
control tests; molecular diagnostic analysis; investigation
and analysis of body substances and molecular diagnostic
test scores for the purpose of the development of new
biomarkers; development and diagnostic testing of treatment
methods; development and testing services for the
certification of quality or standards of (molecular)
diagnostic tests; computer aided diagnostic testing
services; scientific research for medical purposes in the
area of cancerous diseases; genetic testing for scientific
research purposes; research in the field of gene therapy;
research and diagnostic testing services in the field of
skin cancer
44
Medical analysis services; medical analysis services using
test scores and data for medical or veterinary purposes for
others; medical and veterinary information services provided
via the internet; medical testing for diagnostic or
treatment purposes; medical diagnostic services; medical
analysis services for cancer diagnosis and prognosis;
medical services for the treatment of skin cancer; medical
analysis services for the diagnosis of cancer
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| July 22, 2022 | 2022/30 Gaz | US | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| April 12, 2022 | 2022/21 Gaz | AU | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| December 2, 2021 | 2021/48 Gaz | JP | Rejection |
| August 18, 2021 | 2021/33 Gaz | GB | Rejection |
| June 16, 2021 | 2021/24 Gaz | EM | Rejection |
| April 8, 2021 | 2021/14 Gaz | US | Rejection |
| February 19, 2021 | 2021/8 Gaz | AU | Rejection |
| October 26, 2020 | 2021/2 Gaz | BX | Registration |
ID: 141572716